# Oral Corticosteroids for Post-infectious Cough in Adults

> **NCT04232449** · PHASE3 · TERMINATED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 32 (actual)

## Conditions studied

- Post-infectious Cough

## Interventions

- **DRUG:** PREDNISON Galepharm Tabl. 20 mg
- **DRUG:** placebo tablets

## Key facts

- **NCT ID:** NCT04232449
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-11-06
- **Primary completion:** 2024-04-30
- **Final completion:** 2024-04-30
- **Target enrollment:** 32 (ACTUAL)
- **Why stopped:** too few patients were included
- **Last updated:** 2024-07-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04232449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04232449, "Oral Corticosteroids for Post-infectious Cough in Adults". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04232449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
